BAM Capital

BAM Capital as of June 30, 2011

Portfolio Holdings for BAM Capital

BAM Capital holds 27 positions in its portfolio as reported in the June 2011 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 37.2 $37M 675k 55.10
Vivus 7.4 $7.4M 906k 8.14
Delcath Systems 6.5 $6.5M 1.3M 5.16
Elan Corporation 6.4 $6.4M 562k 11.37
Keryx Biopharmaceuticals 5.6 $5.6M 1.2M 4.73
Targacept 5.5 $5.5M 259k 21.05
Amarin Corporation (AMRN) 4.7 $4.7M 322k 14.47
Gen-Probe Incorporated 4.2 $4.2M 61k 69.15
Biogen Idec (BIIB) 3.6 $3.6M 33k 106.91
VirnetX Holding Corporation 3.2 $3.2M 112k 28.94
Spdr S&p 500 Etf (SPY) 2.6 $2.6M 20k 131.95
Pharmasset 2.5 $2.5M 22k 112.18
Best Buy (BBY) 1.5 $1.5M 46k 31.42
Ariad Pharmaceuticals 1.2 $1.2M 110k 11.33
AVEO Pharmaceuticals 1.1 $1.1M 54k 21.00
XenoPort 1.1 $1.1M 157k 7.12
Acorda Therapeutics 1.1 $1.1M 33k 32.30
Dendreon Corporation 0.9 $925k 23k 39.57
Forest Laboratories 0.9 $858k 22k 39.36
Human Genome Sciences 0.7 $676k 28k 24.58
BioMimetic Therapeutics 0.7 $686k 134k 5.12
Orexigen Therapeutics 0.5 $530k 333k 1.59
Onyx Pharmaceuticals 0.5 $536k 15k 35.00
Eli Lilly & Co. (LLY) 0.3 $289k 7.7k 37.53
Genvec 0.1 $125k 39k 3.24
Raptor Pharmaceutical 0.1 $77k 13k 6.16
GTx 0.1 $59k 12k 4.76